How long-range inhibitory brain circuits help form memories

Long-range GABAergic inhibition coordinates hippocampal-subcortical circuit activity in memory formation

NIH-funded research Case Western Reserve University · NIH-11289408

This project is learning how specific hippocampal brain cells that send calming signals to other regions help form and retrieve memories, with relevance to Alzheimer’s disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCase Western Reserve University NIH-funded
Lab location1 site (Cleveland, United States)
Project IDNIH-11289408 on NIH RePORTER

What this research studies

You would hear that researchers are mapping a special group of inhibitory brain cells in the hippocampus that send signals far away to other memory-related regions. The team uses animal models with tracing methods, light-activated proteins (optogenetics), and electrical recordings to see which cells connect where and how they control rhythmic activity important for memory. Early lab work shows somatostatin-expressing cells in the CA3 area project to medial septum and supramammillary nucleus and can inhibit target neurons. This basic research aims to link those circuit effects to the processes of encoding and retrieving memories that break down in Alzheimer’s disease.

Who could benefit from this research

Good fit: People with Alzheimer’s disease or noticeable memory problems could be future candidates for related clinical work or sample donation as this line of research progresses.

Not a fit: Patients seeking immediate treatment or those with non-memory-related conditions are unlikely to see direct benefit from this basic lab-focused work.

Why it matters

Potential benefit: If successful, this work could reveal new brain circuit targets that might guide future therapies to improve memory in Alzheimer’s disease.

How similar studies have performed: Related animal studies using tracing and optogenetics have mapped long-range inhibitory pathways, but translating these findings toward human treatments is still new.

Where this research is happening

Cleveland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.